These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9238187)

  • 21. 5-Azacytidine and fetal hemoglobin.
    Heller P; DeSimone J
    Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on foetal haemoglobin in Khartoum hospital.
    Ibrahim SA
    J Trop Med Hyg; 1969 Dec; 72(12):298-300. PubMed ID: 5387058
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New drugs for childhood anemia.
    La Spina M; Russo G
    Minerva Pediatr; 2003 Oct; 55(5):483-93, 493-8. PubMed ID: 14608271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
    Fathallah H; Atweh GF
    Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
    J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of fetal hemoglobin synthesis in the hemoglobinopathies.
    Nathan DG
    Ann N Y Acad Sci; 1985; 445():177-87. PubMed ID: 2409870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anomalies of hemoglobin synthesis as a cause of disease in childhood].
    Russo G
    Pediatria (Napoli); 1967; 75(3):369-99. PubMed ID: 4886665
    [No Abstract]   [Full Text] [Related]  

  • 30. Hematopoietic cell transplantation for hemoglobinopathies.
    Krishnamurti L; Bunn HF; Williams AM; Tolar J
    Curr Probl Pediatr Adolesc Health Care; 2008 Jan; 38(1):6-18. PubMed ID: 18068866
    [No Abstract]   [Full Text] [Related]  

  • 31. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 32. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation for hemoglobinopathies.
    Mentzer WC
    Curr Opin Hematol; 2000 Mar; 7(2):95-100. PubMed ID: 10698295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 37. Relation of beta to gamma synthesis during the first trimester: an approach to prenatal diagnosis of thalassemia.
    Cividalli G; Nathan DG; Kan YW; Santamarina B; Frigoletto F
    Pediatr Res; 1974 May; 8(5):553-60. PubMed ID: 4825524
    [No Abstract]   [Full Text] [Related]  

  • 38. Does erythropoietin have a role in the treatment of β-hemoglobinopathies?
    Fibach E; Rachmilewitz EA
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):249-63. PubMed ID: 24589265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemoglobinoses].
    Orsini A
    Arch Fr Pediatr; 1978 Apr; 35(4):448-56. PubMed ID: 686953
    [No Abstract]   [Full Text] [Related]  

  • 40. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.